| Institution: | 1. Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain;2. Department of Medical Oncology, Institutul Oncologic Prof. Dr. Ion Chiricuta and University of Medicine and Pharmacy Iulia Hatieganu, Cluj-Napoca, Romania;3. Department of Lung Cancer and Chest Tumours, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland;4. Department of Hematology/Oncology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;5. Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts;6. The Ohio State University-James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio;7. Orientation Oncologique, Hôpital Sainte-Musse, Toulon, France;8. Department of Medicine, Duke University School of Medicine, Durham, North Carolina;9. Department of Medical Oncology, Sf Nectarie Oncology Center, Craiova, Romania;10. Fourth Oncology Department and Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece;11. Medical Oncology Department, Hospital Universitario Virgen Del Rocio, Instituto de Biomedicina de Seville, Seville, Spain;12. Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain;13. Chemotherapy Department, Ambulatorium Chemioterapii, Bydgoszcz, Poland;14. Medical Oncology, Chungbuk National University Hospital, Cheongju-si, Republic of Korea;15. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea;p. Medical Oncology Department, Santa Maria Hospital, Terni, Italy;q. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia;r. Thoracic Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology PLLC, Nashville, Tennessee;s. Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland;t. Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungClinic, Grosshansdorf, Germany;u. Princess Alexandra Hospital, Translational Research Institute and Queensland University of Technology, Brisbane, Queensland, Australia;v. Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France;w. Lung Unit, Royal Marsden Hospital, London, United Kingdom;x. The Institute of Cancer Research, University of London, London, United Kingdom;y. Oncology Department, Lausanne University Hospital, Lausanne, Switzerland;z. Global Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, New Jersey;11. OneClinical, Bristol Myers Squibb, Princeton, New Jersey;22. Hematology and Oncology Department, Fox Chase Cancer Center, Temple Health System, Philadelphia, Pennsylvania;1. University Hospitals Seidman Cancer Center, Cleveland, Ohio;2. Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, New York;3. Center for Thoracic Oncology, Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, New York;4. Pathology Unit, Department of Experimental Oncology, Mediterranean Institute of Oncology, Catania, Italy;5. Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York;6. Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York;7. Department of Family, Population & Preventive Medicine, Stony Brook University, Stony Brook, New York;8. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy;1. Massachusetts General Hospital Cancer Center, Boston, Massachusetts;2. Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts;3. Pfizer, Collegivelle, Pennsylvania;4. Pfizer, Milan, Italy;5. Department of Medicine, Albany Medical College, Albany, New York;6. Pfizer, La Jolla, California;1. Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil;2. Columbia University Medical Center, New York, New York;3. Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom;4. 3rd Department of Medicine, Medical School, National & Kapodistrian University of Athens, Athens, Greece;5. Instituto Alexander Fleming, Buenos Aires, Argentina;6. Wakayama Medical University, Wakayama, Japan;7. Cancer Hospital of Jilin Province, Changchun, People’s Republic of China;8. Clinical Research Center, Pesochny, St. Petersburg, Russian Federation;9. The Christie NHS Foundation Trust, Manchester, United Kingdom;10. Sumy State University, Sumy Regional Oncology Centre, Sumy, Ukraine;11. Korea University, Seoul, South Korea;12. E. J. Zeyland Wielkopolska Center of Pulmonology and Thoracic Surgery, Poznań, Poland;13. Rabin Medical Center, Petah Tikva, Israel;14. Hacettepe University Cancer Institute, Ankara, Turkey;15. Medical Oncology Clinic, MHAT, Nadezhda, Sofia, Bulgaria;p. AstraZeneca, Gaithersburg, Maryland;q. AstraZeneca, Cambridge, United Kingdom;r. State Key Laboratory of South China, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, People’s Republic of China;1. Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan;2. Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan;3. Health Promotion Administration, Ministry of Health and Welfare, Taipei, Taiwan;4. Institute of Statistical Science, Academia Sinica, Taipei, Taiwan;5. Cancer Administration and Coordination Center of National Taiwan University Hospital, Taipei, Taiwan;6. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan;1. Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China;2. Department of Thoracic Medical Oncology, Lung Cancer Diagnosis and Treatment Centre, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre for Cancer, Tianjin, People’s Republic of China;3. Department of Thoracic Medical Oncology, Cancer Hospital of University of Chinese Academy of Sciences and Zhejiang Cancer Hospital, Hangzhou, People’s Republic of China;4. The First Hospital of China Medical University, Shenyang, People’s Republic of China;5. Department of Oncology, Jiangsu Province Hospital, Nanjing, People’s Republic of China;6. The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, People’s Republic of China;7. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Medical Oncology, Peking University Cancer Hospital and Institute, Beijing, People’s Republic of China;8. Department of Medical Thoracic Oncology, Jilin Cancer Hospital, Changchun, People’s Republic of China;9. State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Centre/National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China;10. Hubei Cancer Hospital, Wuhan, People’s Republic of China;11. Jiangxi Cancer Hospital, Nanchang, People’s Republic of China;12. Clinical Center Vitamed and Sechenov University, Moscow, Russia;13. Acibadem Health Group- Adana Acibadem Hospital/Medical Oncology, Adana, Turkey;14. Pavlov First State Medical University, Saint-Petersburg, Russia;15. BHI of Omsk Region Clinical Oncology Dispensary, Omsk, Russia;p. BeiGene (Beijing) Co., Ltd., Beijing, People’s Republic of China;q. BeiGene USA, Inc., Emeryville, California;r. Department of Cancer and Blood, Auckland City Hospital, Auckland, New Zealand |
